SEC Form 4 · accession 0001144204-15-000237
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Drew Bernstein
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 2, 2015 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.73 | Jan 2, 2015 | A | 28,000 | A | — | Jan 1, 2025 | Common stock, par value $0.001 per share | 28,000 | 28,000 | D |
Explanation of responses
- F1On January 2, 2015 (the "Grant Date"), the Reporting Person was granted an option to purchase 28,000 shares of the Issuer's common stock of, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan and pursuant to the Issuer's Director Compensation Plan. This option was fully vested on the Grant Date.